Variables | Frequencies | Pourcentage (%) |
Tumour Stage |
|
|
Localized PCa | 23 | 7.2 |
Localized low risk | 13 | 4.08 |
Localized intermediate risk | 10 | 3.18 |
Localized high risk | 7 | 2.20 |
Locally advanced PCa | 116 | 36.5 |
Metastatic PCa | 179 | 56.3 |
Therapeutic aspects |
|
|
Radical Prostatectomy | 10 | 3.18 |
Bilateral pulpectomy (surgery castration) | 71 | 22.3 |
Antiandrogen | 161 | 50.6 |
Bilateral Pulpectomy + Antiandrogen | 23 | 7.25 |
LHRH analogue | 15 | 4.75 |
Evolution (1 year) |
|
|
Survival rate | 291 | 91.50 |
Mortality rate | 27 | 8.50 |
Local recurrence after prostatectomy | 9 | 3 |